Abstract: Retinoic acid (RA), a derivative of vitamin A, is essential for normal patterning and neurogenesis during development. Until recently, studies have been focused on the physiological roles of RA receptors (RARs), one of the two types of nuclear receptors, whereas the functions of the other nuclear receptors, retinoid X receptors (RXRs), have not been explored. Accumulating evidence now suggests that RXR␣ is a critical receptor component mediating the effects of RA during embryonic development. In this study, we have examined the expression profiles of RXR␣ and RARs during the RA-induced neuronal differentiation in a human embryonal carcinoma cell line, NT2. Distinct expression profiles of RXR␣, RAR␣, RAR␤, and RAR␥ were observed following treatment with RA. In particular, we found that RA treatment resulted in a biphasic up-regulation of RXR␣ expression in NT2 cells. The induced RXR␣ was found to bind specifically to the retinoid X response element based on gel mobility retardation assays. Furthermore, immunocytochemical analysis revealed that RXR␣ expression could be localized to the somatoaxonal regions of the NT2 neurons, including the tyrosine hydroxylase-and vasoactive intestinal peptide-positive neurons. Taken together, our findings provide the first demonstration of the cellular localization and regulation of RXR␣ expression in NT2 cells and suggest that RXR␣ might play a crucial role in the cellular functions of human CNS neurons.
Retinoic acid (RA), a derivative of vitamin A, is important for the maintenance of normal growth and development (Morriss-Kay and Sokolova, 1996) . It is a natural morphogen that determines anteroposterior axial patterning as well as neuronal differentiation (Conlon, 1995; Papalopulu and Kintner, 1996) . RA induces the differentiation of many cell types, including neuronal precursor cells and epithelial cells (De Luca, 1991; Cheung and Ip, 1998) . Clinically, it has been used as an effective therapeutic agent for the treatment of acute promyelocytic leukemia (Warrell et al., 1991) . Based on the importance of RA in the embryogenesis of vertebrates and its potential use as therapeutic agents for cancer cells, many of the studies have been focused on elucidating the mechanism of action of RA.
RA acts on target cells via two classes of nuclear receptors that belong to the nuclear hormone receptor family. The RA receptors (RAR␣, RAR␤, and RAR␥) bind to both all-trans (t)-RA and 9-cis (9c)-RA, whereas the retinoid X receptors (RXR␣, RXR␤, and RXR␥) bind only to 9c-RA (Chambon, 1996) . The retinoid signal is transduced by the formation of RXR/RAR heterodimers, which bind to the RA response elements (RAREs) to activate the gene expression of RA-responsive genes (Kastner et al., 1997) . These RARs have been demonstrated to be important in tumor differentiation, including myeloid leukemia cells and human embryonal carcinoma (EC) cells (Collins et al., 1990; Simeone et al., 1990) . Whereas RAR␣ is essential for the responsiveness of HL-60 cells to t-RA, RAR␥ overexpression can restore the RA-induced terminal mesenchymal differentiation of RA-resistant human EC cells (Moasser et al., 1995) . Although extensive studies have been focused on the roles of RARs, little is known of the importance of the RXRs, especially during RA-induced neuronal differentiation.
Although RXR/RAR heterodimers bind more effectively to the RAREs, RXRs alone can also form homodimers that bind to the retinoid X response elements (RXREs) with high affinity (Zhang et al., 1992) . Thus, it has been proposed that RXRs can acquire different functional roles by homodimerization of the receptors. The diverse but unique expression of RXRs also suggests the possible involvement of RXRs in various physiological functions as well as in different aspects of development and neurogenesis . The importance of RXRs is further exemplified by recent knockout studies (Kastner et al., 1997) . For example, RXR␣ Ϫ/Ϫ mice died at early embryonic stages and exhibited cardiac defects characteristic of the vitamin A deficiency syndrome (Sucov et al., 1994) . Although accumulating evidence supports the involvement of RXR␣ in muscle development, similar roles in neuronal differentiation remain to be elucidated. A low level of expression of RXR␣ transcript was previously detected in the CNS of the mouse embryo Dolle et al., 1994) , and a recent study on the expression of RXR␣ revealed its association with the rostrocaudal patterning of the neural tube (Hoover and Glover, 1998) . Although several studies confirmed the expression of RXR␣ in the developing CNS and proposed the involvement of RXR␣ in neural development, the role of RXR␣ during the neuronal differentiation of the neuronal precursor cells has not been explored.
In the present study, we employed a human cell line, NT2 cells, as a model system to examine the role of RXR␣ during RA-induced neuronal differentiation in the human CNS. NT2 cells have been used extensively as model systems for studying both neurodegenerative diseases such as Alzheimer's disease and the molecular mechanisms of RA actions (Cheung et al., 1996; Maerz et al., 1998) . When treated with RA for Ͼ4 weeks, NT2 cells differentiate into postmitotic CNS neurons (Pleasure et al., 1992) . The RA-induced neuronal differentiation of NT2 cells requires continuous exposure to t-RA (Andrews, 1984) , suggesting the possible involvement of RA at the later stages of RA-induced neuronal differentiation of NT2 cells. In this study, we examined both the transcript and the protein expression of RXR␣ and RARs during prolonged treatment with RA in NT2 cells as well as the subcellular localization of RXR␣. These findings provide potential insights into our understanding of the functional roles of RXR␣ during RA-induced neuronal differentiation.
MATERIALS AND METHODS

Cell culture
NT2 cells were cultured in Opti-MEM I medium (Gibco) supplemented with 5% fetal bovine serum (Gibco) as previously described (Pleasure et al., 1992; Cheung et al., 1997) . The cells were differentiated with either t-RA (2 or 10 M; Sigma) or 9c-RA (2 or 10 M; Sigma) in Dulbecco's modified Eagle's medium (high glucose formulation) supplemented with 10% fetal bovine serum. NT2 neurons were prepared using either the monolayer approach or the cell aggregation method as described (Pleasure et al., 1992; Cheung et al., 1999) .
Immunocytochemical analysis
NT2 neuron cultures were fixed with 2.5% paraformaldehyde (Fluka) in phosphate-buffered saline (PBS). Cells were blocked with 4% normal serum (Vector Laboratories) in PBS containing 0.25% Triton-X (TX; Roche Molecular Biochemicals) and 2% bovine serum albumin (Sigma) and were incubated overnight at 4°C with primary antibodies diluted in antibody diluent (4% normal serum, 0.25% TX, and 2% bovine serum albumin). Incubation with secondary antibodies was performed at room temperature for at least 2 h. Polyclonal rabbit antisera detecting different RARs (␣, ␤, ␥) and RXRs (␣, ␤, ␥) were obtained from Santa Cruz; polyclonal rabbit antityrosine hydroxylase (anti-TH) was obtained from Chemicon. Rabbit polyclonal antibody specific for vasoactive intestinal peptide (VIP; Sigma) and monoclonal mouse antisera specific for phosphorylated neurofilament 160 kDa (NF-M-P; Zymed) and microtubule-associated protein 2 (MAP2; Zymed) were used in the present study. Alexa488 or Alexa568-conjugated goat anti-rabbit IgG and goat anti-mouse IgG (Molecular Probes) were used as secondary antibodies. Positive signals were not obtained using secondary antibodies alone; specificity of the signals detected by the RXR␣ antibody was confirmed when the immunoreactivity was blocked following preabsorption with the specific peptide (data not shown).
Protein extraction and western blot analysis
Cells were washed with ice-cold PBS followed by ice-cold PBS supplemented with 1 mM sodium orthovanadate and Complete protease inhibitor cocktail (Complete; Roche Molecular Biochemicals). Cells were then lysed with lysis buffer [50 mM Tris-Cl (pH 8), 150 mM NaCl, 1% TX, 1ϫ aprotinin (Sigma), 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 1ϫ Complete] at 4°C for 15 min. Lysates were collected and centrifuged to remove cell debris. Protein assays were performed with the Bio-Rad Protein Assay Kit. Protein samples (typically 20 g) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in 10% resolving gel using a Bio-Rad minigel apparatus and then electrotransferred to nitrocellulose membrane (Amersham-Pharmacia Biotech). After blocking at room temperature for 1 h using Trisbuffered saline/Tween containing 5% nonfat milk, membranes were incubated overnight at 4°C with primary antibodies in Tris-buffered saline/Tween containing 5% nonfat milk. Membranes were then incubated with 1:1,500 horseradish peroxidase-conjugated secondary antibodies (Amersham-Pharmacia Biotechnology) for 1 h at room temperature. After three washes with Tris-buffered saline/Tween, immunoreactive bands were detected using an ECL kit (Amersham-Pharmacia Biotechnology) and visualized by Fuji x-ray film.
RNA preparation and RT-PCR analysis
Total RNA was prepared using Trizol reagent (Gibco). Equal amounts (2 g) of total RNA were prepared from NT2 cells after treatment with RA for various periods (1-21 days) and used for RT with Superscript II reverse transcriptase (Gibco). One-twentieth of the reaction was amplified using HIFI Taq DNA polymerase (Gibco) with specific primers. For RXR␣, gene expression was confirmed by using different number of PCR cycles, and Southern blot analysis was performed using specific human RXR␣ cDNA probes.
Gel retardation assays
Gel retardation assays were performed as described with minor modifications (Hope and Struhl, 1987) . In brief, nuclear extracts prepared from NT2 cells that were treated with t-RA for 5 days were incubated with radioactively labeled oligonucleotides in 1ϫ binding buffer containing 20 mM Tris-HCl, 50 mM KCl, 3 mM MgCl 2 , 1 mM EDTA, 100 g/ml gelatin, and 1 g of poly(dI-dC) at pH 7.4. Incubation was performed at room temperature for 20 min. The reaction mixtures were electrophoresed in a 5% nondenaturating polyacrylamide gel containing 0.5ϫ Tris/borate/EDTA for 3 h. The probe used included the oligonucleotide RXRE (5Ј-AGC TGT CAC AGG TCA CAG GTC ACA GGT CAC AGT TCA AGC T) encoding the RXRE of the rat cellular retinol binding protein. It was previously demonstrated that the human RXR␣ could bind to this oligonucleotide in gel retardation assay (Mangelsdorf et al., 1991) . As a control, the oligonucleotide RARE (5Ј-AGC TTA AGG GTT CAC CGA AAG TTC ACT CGC ATA GCT) containing the RARE from RAR␤ promoter (Sucov et al., 1990 ) was used. The nonsense oligonucleotide NS (5Ј-AGC TCT CTG TTC TCC TGG TGT TCT GAA GCT) was used as a negative control in the gel retardation assays. In the competition assays, in addition to the unlabeled RXRE, RARE, and NS, oligonucleotides encoding the consensus sequences of different transcription factors such as AP2 (5Ј-GAT CGA ACT GAC CGC CCG CGG CCC GT) and SP1 (5Ј-ATT CGA TCG GGG CGG GGC GAG C) were also employed.
RESULTS
Expression of RXR transcripts in NT2 cells
The expression of RXR isoforms in NT2 cells was studied using RT-PCR analysis. Total RNA was prepared from untreated or RA-treated (day 14) NT2 cells, and specific primers that amplified different isoforms (␣, ␤, and ␥) of human RXRs were used for the analysis (Table 1) . Amplified products were cloned into pBluescript KS ϩ , and DNA sequencing was performed to confirm their identities. All isoforms of RXRs (␣, ␤, and ␥) were found to be expressed in both untreated and RA-treated NT2 cells (Fig. 1) , and the expression was not affected after 14 days of RA treatment. A detailed time course study was performed to examine the expression of RXR␣ transcript during the process of RAinduced neuronal differentiation. Specific primers flanking the full-length cDNA of the human RXR␣ were employed for the RT-PCR analysis (Table 1) . Human cyclophilin gene was used as an internal control for the quantity of total RNA as previously described (Cheung et al., 1996) (Fig. 2) . Southern blot analysis using specific human RXR␣ cDNA probes revealed that the expression of RXR␣ transcript was up-regulated along the   FIG. 1. RT-PCR analysis of RXR isoforms in NT2 cells. Total RNA was collected from NT2 cells either cultured in normal medium (Ϫ) or treated with t-RA (10 M) for 14 days (ϩ). An equal amount (2 g) of total RNA was reverse-transcribed using SuperScript II RNaseH Ϫ RT (Gibco). Amplification by PCR was performed using Platinum Taq DNA polymerase (Gibco) in a Robocycler (Stratagene) for 40 cycles. Amplified DNA products representing RXR␣, RXR␤, and RXR␥ were separated on a 1% agarose gel. The ethidium bromide-stained agarose gel is shown. Sizes of the DNA markers are indicated on the left. a The upper primers were the downstream primers and the lower primers were the upstream primers used for the amplification.
b Annealing temperature was determined experimentally (data not shown).
FIG. 2.
Expression of RXR␣ transcript during the RA-induced neuronal differentiation of NT2 cells. NT2 cells were treated with 10 M t-RA for 0 -14 days as indicated. Total RNA was prepared, and RT-PCR (25 cycles) was performed using specific primers (see Table 1 ) amplifying the full length (RXR␣). Upper panel: Results of the subsequent Southern blot analysis performed using specific human RXR␣ cDNA probes generated by the partial RXR␣ primers are shown. Lower panel: The ethidium bromide-stained gel of the amplified partial cDNA fragment of the human cyclophilin gene (CyP) to indicate the equal amount of total RNA used for the analysis is shown. Sizes of the DNA markers are indicated on the left.
course of t-RA treatment. The expression level of RXR␣ peaked at day 3 and then was reduced to its basal level at day 10 (Fig. 2) . Similar results were obtained by reducing the number of PCR cycles (data not shown).
Expression of RXR␣ and RARs following treatment with t-RA and 9c-RA in NT2 cells
Western blot analysis of the expression of RXR␣ protein during the RA-induced neuronal differentiation of NT2 cells revealed a biphasic up-regulation of RXR␣ protein expression (Fig. 3) . The expression of RXR␣ was up-regulated following treatment with 10 M t-RA for 3 days; the expression was subsequently reduced and a high level of RXR␣ expression was observed again at day 21 (Fig. 3) . As RXR␣ could form heterodimers with either RAR␣ or RAR␥ (Chiba et al., 1997) , the expression of RAR␣ and RAR␥ was also examined. Unlike the expression profile of RXR␣, the expression of RAR␣ was rapidly increased after 1 day of t-RA (10 M) treatment and was maintained throughout the 21-day period (Fig. 3) . On the other hand, the expression of RAR␤ was relatively constant during the course of RA treatment, whereas RAR␥ was down-regulated by RA, especially after 5-7 days of t-RA treatment (Fig. 3) . Thus, distinct expression profiles of RXR␣, RAR␣, and RAR␥ were observed during the RA-induced neuronal differentiation of NT2 cells. Similar results were obtained by reducing the final concentration of t-RA to 2 M (data not shown).
Similar to t-RA, treatment of NT2 cells with 9c-RA was previously reported to induce neuronal phenotypes in NT2 cells (Kurie et al., 1993) . To examine whether the expression of RXR␣ and RARs was also regulated by 9c-RA, NT2 cells were treated with 2 M 9c-RA for 1-21 days and western blot analysis was performed. We found the expression profiles of RXR␣, RAR␣, RAR␤, and RAR␥ observed in NT2 cells upon treatment with 2 M 9c-RA were similar to those obtained using t-RA (Fig. 4) . That is, the expression of RAR␣ was up-regulated, RAR␤ was not significantly affected, and RAR␥ expression was down-regulated along the course of 9c-RA treatment. Up-regulation of RXR␣ expression was observed when the NT2 cells were treated with 9c-RA for Ͼ5 days (Fig. 4) . Thus, the changes in the expression profiles of RXR and RARs were independent of the form of RA used to induce the process of neuronal differentiation.
Binding of RXR␣ to RXRE
To examine the binding activities of RXR␣, we performed the gel retardation assays using radioactively labeled DNA probes to examine the interaction of RXR␣ with the RXRE. Band shift was observed when the RXRE oligonucleotides were incubated with nuclear extracts obtained from the RA-treated NT2 cells (Fig. 5) . The intensity of the DNA-protein complex increased with increased amount of nuclear extracts added (Fig.  5A) . The binding was reduced by specific polyclonal antibody that detected the RXR␣ proteins (Fig. 5B) , demonstrating that the DNA-protein complex contained RXR␣. The specificity of the DNA-protein binding was also confirmed by the addition of excess unlabeled RXRE probes, which could prevent the binding (Fig.  5C) . Furthermore, the addition of nonspecific competitors such as NS, AP2, and SP1 could not compete with the RXRE in its binding to RXR␣. These data show that the induced RXR␣ is able to bind specifically to the RXRE, which will trigger the subsequent signaling cascade in RA action. It is noteworthy that the addition of excess unlabeled RARE probes could slightly reduce the binding (data not shown), raising the possibility that the protein complexes that bound to the RXREs might also contain the RXR/RAR heterodimers.
FIG. 4.
Expression of RXR␣, RAR␣, RAR␤, and RAR␥ during the neuronal differentiation of NT2 cells induced by 9c-RA treatment. NT2 cells were treated with 9c-RA (2 M) for 1-21 days as indicated. Total proteins were prepared and western blot analysis was performed using antibodies specific for RXR␣ and different RARs (RAR␣ and RAR␥) as indicated on the right. NF-M-P was used as a control neuronal marker. Positions of the protein size markers are as indicated on the left.
FIG. 3.
Expression of RXR␣, RAR␣, RAR␤, and RAR␥ during the neuronal differentiation of NT2 cells induced by t-RA treatment. NT2 cells were treated with t-RA (10 M) for 1-21 days as indicated. Total proteins were prepared and western blot analysis was performed using antibodies specific for RXR␣ and different RARs (RAR␣ and RAR␥) as indicated on the right. NF-M-P was used as a control neuronal marker. Positions of the protein size markers are as indicated on the left.
EXPRESSION OF RXR␣ IN NT2 CELLS
Subcellular localization of RXR␣ in NT2 neurons
Possible NT2 cell types that might express RXR␣ include the committed CNS precursor cells that are ready to acquire their neuronal phenotypes as well as the terminally differentiated CNS neurons resulting from the prolonged RA treatment. The protein expression of RXR␣ was examined in enriched NT2 neurons. It was demonstrated that enriched NT2 neurons expressed a high level of RXR␣ protein (Fig. 6A) . Furthermore, immunofluorescent staining using specific RXR␣ antibodies demonstrated the expression of RXR␣ in both the somatic region and the neurites of the NT2 neurons (Fig. 6B ).
To further elucidate the possible roles of RXR␣, we have examined the subcellular localization of RXR␣ in the NT2 neurons. Double-staining with antibodies specific for RXR␣ and the dendritic marker (MAP2) revealed the co-localization of MAP2 and RXR␣ at the somatic region of the NT2 neurons (Fig. 7A) . Furthermore, the expression of RXR␣ appeared to be associated with the axonal functions of the CNS neurons. Doublestaining of the NT2 neurons with TH-and VIP-specific antibodies revealed the co-localization of TH or VIP immunoreactivity with RXR␣ in the cell bodies and neurites of the NT2 neurons ( Fig. 7B and C, respectively) . This finding demonstrated that the expression of RXR␣ could be observed in different subpopulations of human CNS neurons.
DISCUSSION
We report here the first study on the expression and regulation of RXR␣ during the prolonged treatment of NT2 cells with RA. The biphasic up-regulation of RXR␣ observed during the RA-induced neuronal differentiation of NT2 cells is independent of the type of RA used. RXR␣ can bind specifically to the RXRE. Furthermore, distinct expression profiles of RXR␣, RAR␣, and RAR␥ were observed during the RA-induced neuronal differentiation of NT2 cells. Our finding on the regulatory profiles of RXR␣ and RARs is consistent with the previous suggestion that RXRs can exert their specific and redundant functions by forming heterodimers with different RARs (Chiba et al., 1997) .
Recent observations suggest that RXR␣ might play essential roles in neuronal differentiation as well as functioning of the CNS neurons. For example, the expression of RXR␣ was detected in the neural tubes of chicken embryos (Hoover and Glover, 1998) . Moreover, a recent report demonstrated the restrictive expression of RXR␣ in developing rat brains, such as the dentate gyrus and cranial nerve nuclei (Zetterström et al., 1999) . To mediate different physiological functions, RXR␣ can form either homodimers or heterodimers with the RARs. Previous studies have reported that the RXR␣/RAR␣ heterodimers mediated the endodermal differentiation of the F9 EC cells (Chiba et al., 1997) and that RXR␣ might be involved in mediating the growth arrest and differentiation of human neuroblastoma cells by forming heterodimers with different RARs (Giannini et al., 1997) . In the present study, we have demonstrated that both t-RA and the 9c-RA could regulate the expression of RXR␣ in a similar manner. As the formation of RXR homodimers could be induced only by 9c-RA Allenby et al., 1993) , our finding is consistent with the possibility that RXR␣ might form heterodimers with RAR␣ to mediate the specific neuronal functions in NT2 cells. Preliminary studies in our laboratory have demonstrated the co-localization of RXR␣ and RAR␣ in the terminally differentiated NT2 neurons (data not shown).
The expression of RXR␣ in the cell bodies and neurites of enriched NT2 neurons, as reported in this study, suggests that RXR␣ might also mediate the cellular   FIG. 5 . Gel retardation assays demonstrate the binding of RXR␣ to the RXRE. A: Nuclear extracts from 4 ϫ 10 5 NT2 cells (ϩ) were mixed with radioactively labeled oligonucleotides NS and RARE (lanes 2 and 4). Nuclear extracts equivalent to different numbers of NT2 cells (2 ϫ 10 5 , 4 ϫ 10 5 , and 6 ϫ 10 5 ) were mixed with radioactively labeled RXRE. No nuclear extract (Ϫ) was added in the negative control reactions. B: Nuclear extracts from 4 ϫ 10 5 NT2 cells were mixed with radioactively labeled RXRE. Where indicated (ϩ), the specific polyclonal anti-RXR␣ antibodies were added. C: Similar gel retardation assays were performed by mixing nuclear extracts (4 ϫ 10 5 NT2 cells) with radioactively labeled RXRE. As indicated, a 1-or 50-fold molar excess of unlabeled oligonucleoides (RXRE, RARE, AP2, SP1, and NS) was added. Incubation mixtures were resolved in a 5% polyacrylamide gel in 0.5ϫ Tris/borate/EDTA. The specific RXRE-RXR␣ complexes (arrowheads) and the free radioactively labeled oligonucleotides (F.O.) are indicated.
functions of the CNS neurons. Furthermore, doublestaining of the NT2 neurons demonstrated the co-localization of MAP2 and RXR␣ at the somatic regions of the NT2 neurons. As MAP2 is a cytoskeletal protein localized at the dendrites (Garner et al., 1988; Morales and Fifkova, 1989) , our findings suggested the association of RXR␣ with the somatoaxonal functions of the CNS neurons. It is noteworthy to observe that there is also a strong association between the RXR␣ immunoreactivity and the TH or VIP immunoreactivities. Because they represent two different neuronal populations in the CNS, namely, dopaminergic and GABAergic (Csillik et al., 1998) , RXR␣ might potentially play a role in the neuronal functions of both the excitatory and the inhibitory CNS neurons.
The expression of RAR␥ during RA-induced neuronal differentiation was also examined in this study. This receptor component has previously been suggested to be important in mediating the RA-induced neuronal differentiation when the expression of RAR␥ was found to be absent in RA-resistant NT2 cells (Moasser et al., 1994) . Although these RA-resistant NT2 cells resume their abilities to differentiate when transfected with RAR␥, they do not differentiate into neurons but become mesenchymal cells (Moasser et al., 1995) . Our findings on the reduced expression of RAR␥ at the later stages of neuronal differentiation suggest that the terminal differentiation of NT2 cells might require the participation of receptor molecules other than RAR␥.
In summary, our studies provide the first demonstration of the expression profile of RXR␣, RAR␣, RAR␤, and RAR␥ following prolonged treatment with RA. Taken together with the finding of the ability of induced RXR␣ to bind specifically to RXRE and the demonstration of RXR␣ expression in the somatoaxonal regions of the NT2 neurons, our observations suggest that RXR␣ might play an important role in mediating the RA signaling and in the cellular functions of populations of human CNS neurons. 
